- $537.51m
- $937.76m
- $756.63m
- 92
- 94
- 68
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 629 | 394 | 689 | 1,050 | 757 |
Cost of Revenue | |||||
Gross Profit | 452 | 262 | 476 | 687 | 517 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 418 | 504 | 503 | 621 | 486 |
Operating Profit | 211 | -111 | 186 | 429 | 271 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 170 | -185 | 128 | 395 | 215 |
Provision for Income Taxes | |||||
Net Income After Taxes | 57.8 | -233 | 61.1 | 224 | 111 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 57.8 | -233 | 61.1 | 224 | 111 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 57.8 | -233 | 61.1 | 224 | 111 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1 | -2.41 | 1.03 | 3.75 | 2.06 |
Dividends per Share |